Index -
P/E -
EPS (ttm) -2.72
Insider Own 41.45%
Shs Outstand 24.89M
Perf Week -2.48%
Market Cap 39.32M
Forward P/E -
EPS next Y -2.00
Insider Trans 0.00%
Shs Float 14.66M
Perf Month -22.08%
Income -53.45M
PEG -
EPS next Q -0.50
Inst Own 19.26%
Short Float 3.58%
Perf Quarter -9.25%
Sales 11.91M
P/S 3.30
EPS this Y 48.98%
Inst Trans -7.90%
Short Ratio 8.64
Perf Half Y 28.69%
Book/sh -1.95
P/B -
EPS next Y 13.04%
ROA -149.23%
Short Interest 0.53M
Perf Year -62.35%
Cash/sh 0.83
P/C 1.88
EPS next 5Y 30.00%
ROE -
52W Range 0.73 - 5.23
Perf YTD -59.95%
Dividend Est. -
P/FCF -
EPS past 5Y 21.16%
ROI -558.51%
52W High -69.98%
Beta 0.55
Dividend TTM -
Quick Ratio 1.34
Sales past 5Y 18.48%
Gross Margin 24.25%
52W Low 115.07%
ATR (14) 0.12
Dividend Ex-Date -
Current Ratio 1.50
EPS Y/Y TTM 55.49%
Oper. Margin -320.01%
RSI (14) 38.94
Volatility 7.49% 6.73%
Employees 134
Debt/Eq -
Sales Y/Y TTM -0.79%
Profit Margin -448.86%
Recom 2.00
Target Price 1.00
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q -1040.16%
Payout -
Rel Volume 0.86
Prev Close 1.70
Sales Surprise -1.65%
EPS Surprise -15.34%
Sales Q/Q -9.82%
Earnings Nov 07 AMC
Avg Volume 60.80K
Price 1.57
SMA20 -10.00%
SMA50 -13.05%
SMA200 15.48%
Trades
Volume 53,164
Change -7.65%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-09-22 Downgrade
Craig Hallum
Buy → Hold
$5
Oct-08-20 Initiated
BTIG Research
Neutral
Aug-07-20 Upgrade
Craig Hallum
Hold → Buy
$20
Sep-27-19 Downgrade
JP Morgan
Neutral → Underweight
$16
Nov-07-18 Downgrade
JP Morgan
Overweight → Neutral
May-24-18 Initiated
Craig Hallum
Hold
$25
Dec-13-17 Downgrade
BTIG Research
Buy → Neutral
Jul-12-17 Resumed
BTIG Research
Buy
$34
Mar-24-16 Initiated
JP Morgan
Overweight
$17
Dec-16-15 Initiated
Piper Jaffray
Overweight
Nov-08-24 09:15AM
(Thomson Reuters StreetEvents) -7.11%
02:28AM
Nov-07-24 05:40PM
04:32PM
(Associated Press Finance)
04:05PM
04:30PM
Loading…
Oct-25-24 04:30PM
Oct-09-24 05:56PM
Oct-01-24 06:33AM
(Medical Device Network) +8.19%
Sep-30-24 09:15AM
Aug-14-24 10:05AM
Aug-08-24 05:45PM
04:41PM
(Associated Press Finance)
04:05PM
04:00PM
11:09AM
12:28PM
Loading…
May-09-24 12:28PM
06:04AM
(Thomson Reuters StreetEvents)
03:43AM
May-08-24 09:57PM
06:25PM
05:22PM
(Associated Press Finance)
04:42PM
May-02-24 10:01AM
09:30AM
Apr-02-24 10:51AM
Mar-29-24 05:57AM
(Thomson Reuters StreetEvents)
Mar-28-24 09:53PM
05:45PM
04:05PM
Mar-07-24 09:30AM
09:20AM
Loading…
Jan-19-24 09:20AM
Jan-16-24 07:45AM
Jan-07-24 08:00PM
Nov-29-23 08:43AM
Nov-27-23 09:15AM
Nov-22-23 09:35AM
Nov-11-23 10:44AM
Nov-09-23 06:42PM
(Associated Press Finance)
04:05PM
Oct-30-23 09:30AM
Oct-03-23 08:50AM
Sep-14-23 11:01PM
Aug-11-23 05:59AM
(Thomson Reuters StreetEvents)
Aug-10-23 05:30PM
04:26PM
(Associated Press Finance)
04:05PM
Jul-27-23 09:30AM
Jul-10-23 09:00AM
Jun-29-23 09:40AM
Jun-13-23 09:40AM
09:00AM
07:03AM
May-23-23 09:40AM
May-12-23 09:53AM
(Thomson Reuters StreetEvents)
May-11-23 05:25PM
04:20PM
04:05PM
09:09AM
May-10-23 11:18AM
10:23AM
09:23AM
Apr-27-23 09:30AM
Apr-19-23 08:38AM
Apr-17-23 06:38AM
(Simply Wall St.) +13.64%
Apr-03-23 12:00PM
Apr-01-23 12:47PM
Mar-29-23 05:25PM
04:05PM
Mar-15-23 09:30AM
Mar-14-23 08:00PM
Mar-08-23 08:30AM
Feb-06-23 05:23AM
Dec-19-22 01:32PM
Nov-16-22 10:22AM
Nov-14-22 04:05PM
(PR Newswire) +5.63%
-18.67%
Oct-24-22 01:52PM
10:02AM
Oct-19-22 01:27PM
Aug-23-22 08:02AM
(Simply Wall St.) +12.59%
Aug-19-22 04:50PM
(American City Business Journals) -49.40%
+13.49%
Aug-18-22 09:30PM
09:28AM
Aug-17-22 06:00PM
Aug-15-22 02:41PM
08:15AM
06:50AM
Jul-28-22 07:09AM
Jul-25-22 09:30AM
Jul-11-22 08:00AM
Jun-13-22 06:55AM
May-23-22 09:30AM
May-16-22 06:15PM
04:05PM
08:06AM
May-12-22 06:25PM
May-10-22 05:55PM
May-05-22 09:00AM
May-04-22 08:25AM
Apr-29-22 09:30AM
Apr-25-22 08:41AM
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PATIENCE JOHN Director Dec 03 '24 Buy 1.57 200,000 314,000 653,224 Dec 03 08:48 PM SCHULER JACK W Director Dec 03 '24 Sale 1.57 200,000 314,000 8,310,388 Dec 03 08:46 PM MASSARANY HANY Director Jun 28 '24 Option Exercise 0.00 4,737 0 36,891 Jul 01 06:32 PM FRANCESCONI LOUISE Director Jun 28 '24 Option Exercise 0.00 4,737 0 33,558 Jul 01 06:31 PM SCHULER JACK W Director Jun 28 '24 Option Exercise 0.00 4,737 0 20,225 Jul 01 06:30 PM BURRIS WAYNE Director May 31 '24 Option Exercise 0.00 839 0 1,678 Jun 03 05:06 PM FRANCESCONI LOUISE Director May 29 '24 Option Exercise 0.00 7,894 0 28,821 May 30 04:25 PM Regan Jennifer Director May 29 '24 Option Exercise 0.00 12,631 0 12,631 May 30 04:25 PM SCHULER JACK W Director May 29 '24 Option Exercise 0.00 7,894 0 15,488 May 30 04:25 PM MASSARANY HANY Director May 29 '24 Option Exercise 0.00 7,894 0 32,154 May 30 04:16 PM Mertz Larry Michael Chief Technology Officer May 20 '24 Option Exercise 0.00 1,283 0 82,114 May 21 07:03 PM Mertz Larry Michael Chief Technology Officer May 20 '24 Sale 0.88 361 318 81,831 May 21 07:03 PM Phillips Jack Chief Executive Officer Apr 17 '24 Option Exercise 0.00 59,928 0 189,654 Apr 18 04:10 PM Phillips Jack Chief Executive Officer Apr 17 '24 Sale 0.78 26,735 20,853 162,919 Apr 18 04:10 PM Phillips Jack Chief Executive Officer Apr 12 '24 Option Exercise 0.00 59,928 0 156,271 Apr 16 04:10 PM Phillips Jack Chief Executive Officer Apr 12 '24 Sale 0.86 26,545 22,829 129,726 Apr 16 04:10 PM Patience David Chief Financial Officer Apr 09 '24 Option Exercise 0.00 37,468 0 63,715 Apr 10 05:27 PM Patience David Chief Financial Officer Apr 09 '24 Sale 0.87 13,296 11,568 50,419 Apr 10 05:27 PM Mertz Larry Michael Chief Technology Officer Apr 09 '24 Option Exercise 0.00 40,633 0 95,090 Apr 10 05:26 PM Mertz Larry Michael Chief Technology Officer Apr 09 '24 Sale 0.87 13,984 12,166 81,106 Apr 10 05:26 PM Mertz Larry Michael Chief Technology Officer Apr 04 '24 Option Exercise 0.00 2,866 0 55,435 Apr 05 04:29 PM Mertz Larry Michael Chief Technology Officer Apr 04 '24 Sale 0.88 978 861 54,457 Apr 05 04:29 PM Phillips Jack Chief Executive Officer Apr 04 '24 Option Exercise 0.00 35,523 0 112,230 Apr 05 04:26 PM Phillips Jack Chief Executive Officer Apr 04 '24 Sale 0.88 15,887 13,981 96,343 Apr 05 04:26 PM Patience David Chief Financial Officer Feb 26 '24 Option Exercise 0.00 1,000 0 26,597 Feb 27 06:59 PM Patience David Chief Financial Officer Feb 26 '24 Sale 0.96 350 336 26,247 Feb 27 06:59 PM Phillips Jack Chief Executive Officer Feb 01 '24 Option Exercise 0.00 1,000 0 77,201 Feb 02 04:48 PM Phillips Jack Chief Executive Officer Feb 01 '24 Sale 1.30 494 642 76,707 Feb 02 04:48 PM Phillips Jack Chief Executive Officer Dec 13 '23 Option Exercise 0.00 1,721 0 60,274 Dec 14 05:15 PM Phillips Jack Chief Executive Officer Dec 13 '23 Sale 4.39 739 3,244 59,535 Dec 14 05:15 PM Patience David Chief Financial Officer Dec 13 '23 Option Exercise 0.00 331 0 9,028 Dec 14 05:14 PM Patience David Chief Financial Officer Dec 13 '23 Sale 4.39 97 426 8,931 Dec 14 05:14 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite